guest ::
| Home > Publications database > Ovine papillomavirus type 3 virus-like particle-based tools for diagnosis and detection of infection. > print |
| Home > Publications database > Ovine papillomavirus type 3 virus-like particle-based tools for diagnosis and detection of infection. > print |
| 001 | 290854 | ||
| 005 | 20250814134742.0 | ||
| 024 | 7 | _ | |a 10.1016/j.vaccine.2024.06.001 |2 doi |
| 024 | 7 | _ | |a pmid:38839520 |2 pmid |
| 024 | 7 | _ | |a 0264-410X |2 ISSN |
| 024 | 7 | _ | |a 1358-8745 |2 ISSN |
| 024 | 7 | _ | |a 1873-2518 |2 ISSN |
| 037 | _ | _ | |a DKFZ-2024-01211 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Cacciotto, Carla |b 0 |
| 245 | _ | _ | |a Ovine papillomavirus type 3 virus-like particle-based tools for diagnosis and detection of infection. |
| 260 | _ | _ | |a Amsterdam |c 2024 |b Elsevier |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1725433670_15636 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a 2024 Sep 17;42(22):126033 |
| 520 | _ | _ | |a The design of prophylactic and diagnostic tools specific to animal papillomaviruses is hampered by the difficulties of viral in vitro manipulation and by the scarce availability of dedicated biotechnological tools. This paper reports the production of Ovine Papillomavirus 3 (OaPV3)-based virus-like particles (OaPV3-VLPs) in the baculovirus system and their use to investigate host humoral immune response through the establishment of an indirect ELISA test., Polyclonal sera and monoclonal antibodies were generated against OaPV3-VLPs, and their isotype and reactivity were determined. Additionally, antibodies allowed OaPV3 detection in ovine squamous cell carcinoma (SCC) samples by immunohistochemistry. Results encourage the standardization of OaPV3-specific prophylactic and serological diagnostic tools, and open new perspectives for the study of host-viral interaction and SCC development. |
| 536 | _ | _ | |a 314 - Immunologie und Krebs (POF4-314) |0 G:(DE-HGF)POF4-314 |c POF4-314 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
| 650 | _ | 7 | |a Animal papillomavirus |2 Other |
| 650 | _ | 7 | |a Oncovirus |2 Other |
| 650 | _ | 7 | |a Serogical diagnosis |2 Other |
| 650 | _ | 7 | |a Skin cancer |2 Other |
| 650 | _ | 7 | |a Vaccines |2 Other |
| 700 | 1 | _ | |a Dore, Gian Mario |b 1 |
| 700 | 1 | _ | |a Cubeddu, Tiziana |b 2 |
| 700 | 1 | _ | |a Burrai, Giovanni Pietro |b 3 |
| 700 | 1 | _ | |a Anfossi, Antonio Giovanni |b 4 |
| 700 | 1 | _ | |a Antuofermo, Elisabetta |b 5 |
| 700 | 1 | _ | |a Varoni, Maria Vittoria |b 6 |
| 700 | 1 | _ | |a Demontis, Maria Piera |b 7 |
| 700 | 1 | _ | |a Zobba, Rosanna |b 8 |
| 700 | 1 | _ | |a Pittau, Marco |b 9 |
| 700 | 1 | _ | |a Müller, Martin |0 P:(DE-He78)47d2c5b8ee00ab8a0c16e14137427579 |b 10 |u dkfz |
| 700 | 1 | _ | |a Alberti, Alberto |b 11 |
| 773 | _ | _ | |a 10.1016/j.vaccine.2024.06.001 |g p. S0264410X24006601 |0 PERI:(DE-600)1468474-3 |n 22 |p 126033 |t Vaccine |v 42 |y 2024 |x 0264-410X |
| 856 | 4 | _ | |u https://inrepo02.dkfz.de/record/290854/files/1-s2.0-S0264410X24006601-main.pdf |
| 856 | 4 | _ | |u https://inrepo02.dkfz.de/record/290854/files/1-s2.0-S0264410X24006601-main.pdf?subformat=pdfa |x pdfa |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:290854 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 10 |6 P:(DE-He78)47d2c5b8ee00ab8a0c16e14137427579 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-314 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Immunologie und Krebs |x 0 |
| 914 | 1 | _ | |y 2024 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2023-10-21 |w ger |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b VACCINE : 2022 |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2023-10-21 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-10-21 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2023-10-21 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b VACCINE : 2022 |d 2023-10-21 |
| 920 | 1 | _ | |0 I:(DE-He78)D335-20160331 |k D335 |l Tumorvirus-spez. Vakzinierungsstrategie |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)D335-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|